zoledronic acid has been researched along with 2,3-bis(2-methoxy-4-nitro-5-sulfophenyl)-5-((phenylamino)carbonyl)-2h-tetrazolium hydroxide in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Draenert, FG; Heymann, PG; Kämmerer, PW; Kretschmer, F; Mandic, R; Neff, A; Saydali, A | 1 |
1 other study(ies) available for zoledronic acid and 2,3-bis(2-methoxy-4-nitro-5-sulfophenyl)-5-((phenylamino)carbonyl)-2h-tetrazolium hydroxide
| Article | Year |
|---|---|
Laser-enhanced cytotoxicity of zoledronic acid and cisplatin on primary human fibroblasts and head and neck squamous cell carcinoma cell line UM-SCC-3.
Topics: Antineoplastic Agents; Apoptosis; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Proliferation; Cell Shape; Cell Survival; Cells, Cultured; Cisplatin; Coloring Agents; Diphosphonates; Fibroblasts; Head and Neck Neoplasms; Humans; Imidazoles; Indicators and Reagents; Lasers, Semiconductor; Low-Level Light Therapy; Photochemotherapy; Photosensitizing Agents; Tetrazolium Salts; Zoledronic Acid | 2014 |